Palliative Care: Physician Communication and Patient Comprehension
The consensus from our audience was almost exactly evenly split between discussing palliative care with patients at the beginning of treatment and after all treatment options have failed.<br><br>Recent research, however, suggests that palliative care as a method to ease the symptoms of cancer treatment is most effective at the onset of treatment.
Very few, only 12%, of respondents indicated that patients understand palliative care before it is explained.<br><br>While this is very much in line with the research, experts have indicated the need for increased broad awareness of palliative care in order to increase the effectiveness and decrease misconceptions and fear surrounding this topic.
Almost all respondents, 98.85% see a need for better training for physicians who are discussing palliative care with their patients.<br><br>To read more about palliative care, visit <a href="http://www.cancertherapyadvisor.com/palliative-care/section/2450/">http://www.cancertherapyadvisor.com/palliative-care/section/2450/</a>.
The Palliative Care in Oncology Symposium recently took place in Boston, Massachusetts, and focused on patient-centered care across the cancer continuum.
With this in mind, Cancer Therapy Advisor conducted a community poll that asked our readers about their experience in dealing with issues surrounding the discussion of palliative care with their patients.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- CAR-T Trial for Triple-Negative Breast Cancer Under Way
- Adjuvant Trastuzumab Emtansine Confers Improved Outcome in KATHERINE Trial
- Extension of Adjuvant Anastrozole Regimen to 10 Years Yields Higher DFS, but Not OS
- Daratumumab Combination: New Standard of Care in Transplant-Ineligible Multiple Myeloma
- Phase 3 GEICAM/CIBOMA Results: Adjuvant Capecitabine in Triple-Negative Breast Cancer
- Risk Score Identifies Adjuvant Chemotherapy Toxicity Risk in Elderly Patients With Breast Cancer
- Despite Breast-Conserving Surgery Eligibility, Nearly 50% of Women Chose Mastectomy
- Lisinopril and Carvedilol May Reduce Cardiotoxicity During Adjuvant Trastuzumab Treatment
- Immune Marker Identified as Prognostic in Triple-Negative Breast Cancer
- Rates of Adverse Events Similar Regardless of IMRT Boost Type